Management of Advanced Stage Hodgkin Lymphoma

By Advani Ranjana   Ai Weiyun Z.   Horning Sandra J.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 4, Iss. 3, 2006-03 ,pp. : 241-247

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: A multi-institutional retrospective study

By Castillo Jorge J.   Bower Mark   Brühlmann Jérémy   Novak Urban   Furrer Hansjakob   Tanaka Paula Y.   Besson Caroline   Montoto Silvia   Cwynarski Kate   Abramson Jeremy S.   Dalia Samir   Bibas Michele   Connors Joseph M.   Furman Michael   Nguyen Minh-Ly   Cooley Timothy P.   Beltran Brady E.   Collins Jaime A.   Vose Julie M.   Xicoy Blanca   Ribera Josep-Maria   Castillo Jorge J.  

Cancer, Vol. 121, Iss. 3, 2015-02 ,pp. : 423-431

Blackwell Publishing

Access to resources Recommend Favorite

Favorable Early-Stage Hodgkin Lymphoma

By Yahalom Joachim  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 4, Iss. 3, 2006-03 ,pp. : 233-240

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

XVI. Early stage Hodgkin lymphoma

By  

Hematological Oncology (Electronic), Vol. 33, Iss. S1, 2015-06 ,pp. : 84-86

John Wiley & Sons Inc

Access to resources Recommend Favorite

Late Effects of Treatment for Hodgkin Lymphoma

By Friedman Debra L.   Constine Louis S.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 4, Iss. 3, 2006-03 ,pp. : 249-257

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite